COMMERZBANK AKTIENGESELLSCHAFT /FI - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.

Quarter-by-quarter ownership
COMMERZBANK AKTIENGESELLSCHAFT /FI ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$16,104,000
+27.5%
692,925
-12.7%
0.16%
+17.0%
Q1 2018$12,635,000
-8.0%
793,684
+20.1%
0.14%
-17.1%
Q4 2017$13,735,000
+15.3%
660,981
-20.5%
0.17%
+8.3%
Q3 2017$11,908,000
+56.1%
830,988
+88.5%
0.16%
+22.7%
Q2 2017$7,627,000
+284.2%
440,873
+144.9%
0.13%
+341.4%
Q1 2017$1,985,000
-75.0%
179,992
-67.1%
0.03%
-75.2%
Q4 2016$7,944,000
+52.4%
547,077
+157.7%
0.12%
+39.3%
Q3 2016$5,211,000
+11.7%
212,263
-8.4%
0.08%
+171.0%
Q2 2016$4,667,000
-12.0%
231,752
+15.0%
0.03%
-29.5%
Q1 2016$5,301,000
-60.4%
201,545
+53.0%
0.04%
-57.3%
Q4 2015$13,388,000
-25.2%
131,709
+31.3%
0.10%
-23.1%
Q3 2015$17,893,000
-21.0%
100,311
-1.6%
0.13%
+12.6%
Q2 2015$22,645,000
+14.4%
101,936
+2.3%
0.12%0.0%
Q1 2015$19,794,000
-10.1%
99,657
-35.2%
0.12%
-15.0%
Q4 2014$22,021,000
+38.0%
153,876
+26.5%
0.14%
+118.8%
Q3 2014$15,957,000
+108.2%
121,625
+100.1%
0.06%
+64.1%
Q2 2014$7,666,000
+80.2%
60,783
+88.4%
0.04%
+116.7%
Q1 2014$4,253,000
+1.0%
32,258
+3.9%
0.02%
-14.3%
Q4 2013$4,211,000
+727.3%
31,048
+536.0%
0.02%
+600.0%
Q3 2013$509,000
-19.3%
4,882
-33.4%
0.00%0.0%
Q2 2013$631,0007,3300.00%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2013
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders